These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004239-78 Förekomst av syrarelaterade besvär efter utsättning av protonpumpshämmare hos friska frivilliga. not-yet-due
Ongoing 2005-000279-16 Phase III Clinical Study of Allogeneic Stem Cell Transplantation with Reduced Conditioning (RICT) versus Best Standard of Care in Acute Myeloid Leukemia (AML) in First Complete Remission not-yet-due
Ongoing 2005-001008-37 Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy not-yet-due
Not reported 2005-001048-22 Rosuvastatin in Visceral Adiposity. A 26-week, single center, randomised, placebo-controlled, double-blind, parallel-group study to evaluate the effect of rosuvastatin on visceral adipose tissue in ma... 2011-03-02 due-trials
Reported results 2005-002756-18 Bortezomib consolidation in patients with myeloma following treatment with high-dose melphalan and autologous stem cell support. A randomised NMSG trial (15/05) 2010-05-01 due-trials
No trial status on register 2005-003287-28 Nitrous oxide for analgesia and sedation during procedural pain in children -Efficacy ina short and long perspective regarding joint injections bad-data
Ongoing 2005-003422-26 Immunological and virological effects of high dose intravenous immunoglobulin (IVIG) treatment added to antiretroviral therapy against HIV not-yet-due
Not reported 2005-003867-21 Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomis... 2007-08-11 due-trials
Not reported 2006-001543-60 FIBRINOGEN OCH BLÖDNING EFTER HJÄRTKIRURGI 2007-01-08 due-trials
Listed as ongoing, but also has a completion date 2006-003409-18 An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Chron... 2013-09-06 bad-data
Ongoing 2007-002224-15 Individual GH dosing using 1st year GH responsiveness for prepubertal growth response in short GHD/ISS children not-yet-due
Not reported 2007-004954-99 Does varenicline influence alcohol consumption in alcohol dependent individuals? 2011-01-21 due-trials
Ongoing 2007-007545-13 Nytt protokoll för ABO-inkompatibel levertransplantation med Mabthera® och immunadsorption: en pilotstudie. not-yet-due
Ongoing 2008-000046-31 A randomised Intervention, Single-Center Study to Determine the Role of Fatty Acids in Serum in preventing not-yet-due
Ongoing 2008-003328-45 Klinisk utvecklingsarbete för utvärdering av molykulärt riktad behandling vid metastaserande njurcancer- PETTO not-yet-due
Exempt 2008-005871-92 En fas 1 studie av effekt av Tysabri (natalizumab), en IgG4 humaniserad monoklonal antikropp specifik mot VLA-4 (integrin alfa-4), administrerad som infusion 1 gång/månad under 3 månader hos patiente... not-yet-due
Ongoing 2009-009039-32 Abciximab versus Eptifibatide versus Bivalirudin during PCI in patients with acute coronary syndromes not-yet-due
Ongoing 2009-012676-27 Femoral-Express-I not-yet-due
Ongoing 2009-015859-24 Effect of zonisamide-induced weight reduction compared to nCPAP in patients with sleep apnoea not-yet-due
Completed, but no date 2009-015926-13 Treatment of Huntington´s disease with OSU 6162 - a pilot study bad-data
Ongoing 2009-016783-37 The Effects of 18-Month Replacement with a Very Low Fixed Dose vs. Standard Dose of Growth Hormone (GH) on Insulin Sensitivity, Body Composition, Bone Mass, Lipids, Muscle Strength and Quality of Life... not-yet-due
Listed as ongoing, but also has a completion date 2010-018332-41 A Randomized, Open-label, Parallel Group, Multicenter Pilot Study Evaluating the Efficacy and Safety of Alternative Dosing of Ribavirin vs. Standard of Care Dosing in Combination with Peginterferon al... 2012-07-31 bad-data
Ongoing 2010-022065-10 Effect of angiogenesis inhibiting therapy in patients progressing on endocrine treatment and patients with triple negative breast cancer - a translational phase II study within the not-yet-due
Other 2010-023293-39 Tryckkammarbehandling vid besvär från urinblåsan som uppkommit efter strålbehandling mot cancer i bäckenregionen. not-yet-due
Ongoing 2010-023681-45 Endotoxin-induced immune response in the lower respiratory tract in smokers with and without chronic bronchitis (CB) and / or chronic obstructive pulmonary disease (COPD) not-yet-due
Ongoing 2011-000813-37 Effects of obeticholic acid on hepatic fatty acid/triglyceride metabolism and hepatobiliary detoxification/elimination in morbidly obese and gallstone patients. not-yet-due
Ongoing 2011-003418-18 A Randomised, Double Blind, Placebo Controlled, Multi-centre, Parallel Group, Interventional Study of Mesalazine (Asacol®) Treatment in IBS and the Evaluation of Rectal Inflammatory Status using the M... not-yet-due
Exempt 2011-004990-10 Double-blind placebo controlled study of the effects of OSU6162 on chronic fatigue in patients who suffered a mild traumatic brain injury not-yet-due
Ongoing 2012-000309-60 Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram not-yet-due
Listed as ongoing, but also has a completion date 2012-000451-13 A controlled randomized, open-label, multi-centre study evaluating if a steroid-free immunosuppressive protocol, based on ATG- induction, low tacrolimus-dose and therapeutic drug monitoring of mycophe... 2019-05-01 bad-data
Ongoing 2012-001381-15 Radiation Induced Cystits treated with Hyperbaric Oxygen. A Randomized controlled Trial not-yet-due
Completed, but no date 2012-002337-11 A multicenter and randomised clinical study on pubertal replacement therapy in boys - Treatment of boys with absent or delayed puberty with rhFSH and two different formulations of testosterone in low ... bad-data
Ongoing 2012-004232-37 Prophylactic treatment with methylprednisolone may reduce the cerebral inflammatory response and reduce the severity of cognitive dysfunction after cardiac surgery not-yet-due
Ongoing 2012-004950-27 Effect of valproic acid on fibrinolysis in humans with atherosclerosis not-yet-due
Not reported 2012-005063-28 Release of substance P during peritoneal dialysis: effects of intervention. Controlled cross-over study of the neurokinin-1 receptor antagonist Aprepitant 2017-11-14 due-trials
Ongoing 2013-000564-29 The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases not-yet-due
Listed as ongoing, but also has a completion date 2013-003105-25 The prophylactic effect of levosimendan in reducing acute kidney injury postoperatively in pediatric patients undergoing corrective heart surgery 2017-04-24 bad-data
Ongoing 2013-004866-33 A short term open, randomized cross over trial trial exploring the effect of carbonic anhydrase inhibition by acetazolamide on sleep apnea associated hypertension not-yet-due
Ongoing 2014-003589-25 The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery not-yet-due
Ongoing 2014-004070-42 An Exploratory, Phase IIa Cross-Over Study to Demonstrate the Efficacy and Safety of A4250 in Patients with Primary Biliary Cirrhosis and Cholestatic Pruritus not-yet-due
Ongoing 2014-005235-13 Therapy-treatment (PDT) on Acne, a study to optimize the number of treatments, the right light-dose and the right pre-treatment in order to obtain a longterm remission-time not-yet-due
Ongoing 2015-001092-49 Valproic acid regulation of plasma PAI-1 not-yet-due
Ongoing 2015-002096-14 Examine whether treatment with methylphenidate facilitates work rehabilitation for persons with long-term pain and mental fatigue after traumatic brain injury. not-yet-due
Ongoing 2015-003310-24 A Phase 3, Open-label, Randomized, Prospective Clinical Trial Evaluating the Efficacy of Stratified Treatment with Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy in ... not-yet-due
Ongoing 2015-003995-65 Pharmacokinetics of ANP, a diuretic hormone, in neonates undergoing surgery for congenital heart defects. A pilot study. not-yet-due
Ongoing 2015-004137-27 A Scandinavian controlled, randomized, open-label, and multi-centre study evaluating if once-daily tacrolimus or twice-daily cyclosporin, reduces the 3-year incidence of chronic lung allograft dysfunc... not-yet-due
Ongoing 2015-004311-20 Effect of vitamin B substitution on plasma NFL and neurocognitive performance in HIV-infected individuals with increased plasma homocysteine not-yet-due
Ongoing 2015-004427-31 Tenofovir Alafenamide Fumarate (TAF) effect on residual intrathecal immune activation not-yet-due
Ongoing 2016-000167-16 DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma: A randomized controlled trial not-yet-due
Ongoing 2016-002114-50 A multicenter phase II open label study to evaluate efficacy of concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma not-yet-due
Exempt 2016-002728-94 A phase I/II, open-label study of safety, immune activation and efficacy of histamine dihydrochloride and low-dose interleukin-2 in adult tyrosine kinase inhibitor-treated patients with chronic myeloi... not-yet-due
Ongoing 2016-003409-33 Optimizing 6-mercaptopurine therapy in paediatric acute lymphoblastic leukemia by using allopurinol not-yet-due
Ongoing 2016-004414-10 Determination of the concentration of Teriflunomide in serum and cerebrospinal fluid from patients with multiple sclerosis who are treated with Teriflunomide 14 mg daily. not-yet-due
Ongoing 2016-004463-39 Influence on cough and airway symptoms by oral capsaicin (capscium oleoresin ) – a phase II, randomised, placebo-controlled clinical study in patients with chronic idiopathic cough not-yet-due
Completed, but no date Terminated 2016-004471-46 Drug level and Investigation of Novel Substances Indicated Downstream Effect in (INSIDE) glioblastoma bad-data
Ongoing 2016-005225-37 The ASTEROID trial - Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An open label randomized phase II trial with durvalumab following Stereotactic Body radiotherapy (SBRT) in patients ... not-yet-due
Completed, but no date Terminated 2017-000368-14 A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD bad-data
Ongoing 2017-001499-43 Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial) not-yet-due
Ongoing 2017-003830-97 Effects of an Opiod Sparing Care Pathway for Patients undergoing Obesity Surgery not-yet-due
Exempt 2017-004200-21 A phase Ib/II randomized double-blind placebo controlled trial evaluating the effect of nivolumab for patients with in-transit melanoma metastases treated with isolated limb perfusion not-yet-due
Completed, but no date 2017-004898-14 See down below. bad-data
Ongoing 2017-005146-30 See below not-yet-due
Completed, report not yet due 2018-001021-10 Brodalumab in a randomised, open, phase IV study evaluating clinical efficacy in psoriasis patients switching from TNF-alpha inhibitor treatment 2020-06-18 not-yet-due
Ongoing 2018-003868-32 See below not-yet-due
Ongoing 2019-004302-10 A randomized controlled open-label single-center study to assess the efficacy of Tocilizumab in treatment of chronic active antibody-mediated rejection in kidney transplant recipients not-yet-due
Ongoing 2019-004758-27 Intravenous immunoglobulin (IVIG) treatment in children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS): an open-label trial in South-western Sweden not-yet-due
Ongoing 2020-000233-41 Labour induction in an outpatient setting - a multicenter randomized controlled trial. OPTION - OutPatienT InductiON not-yet-due
Ongoing 2020-000913-33 Semaglutide and dapagliflozin in diabetic patients with different pathophysiology not-yet-due